Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/35085
Title: In Vivo, in Vitro Toxicity and in Vitro Angiogenic Inhibition of Sunitinib Malate
Authors: Dib, Eduardo [UNIFESP]
Maia, Mauricio [UNIFESP]
Lima, Acacio de Souza
Fiod Costa, Elaine de Paula [UNIFESP]
Moraes-Filho, Milton Nunes de [UNIFESP]
Rodrigues, Eduardo Buechele [UNIFESP]
Penha, Fernando Marcondes [UNIFESP]
Coppini, Larissa Pereira [UNIFESP]
Tenorio de Barros, Nilana Meza [UNIFESP]
Sinigaglia Galli Coimbra, Rita de Cassia [UNIFESP]
Magalhaes Junior, Octaviano [UNIFESP]
Guerra, Tarcisio [UNIFESP]
Furlani, Bruno de Albuquerque [UNIFESP]
Freymuller, Edna [UNIFESP]
Farah, Michel Eid [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
Vis Inst IPEPO
Keywords: Angiogenesis
Choroidal neovascularization
Intravitreal injection
Drug toxicity
Tyrosine kinase inhibitor
Issue Date: 1-Jul-2012
Publisher: Informa Healthcare
Citation: Current Eye Research. London: Informa Healthcare, v. 37, n. 7, p. 567-574, 2012.
Abstract: Purpose: To evaluate the in vivo and in vitro toxicity of sunitinib malate, a multikinase inhibitor molecule.Design: Experimental, Prospective, Controlled.Methods: Human retinal pigment epithelial (ARPE-19) and human umbilical vein endothelialcells (HUVECS) were used in a culture toxicity test and exposed to different concentrations of sunitinib malate for 18 hours. the HUVECs also were cultured to evaluate the angiogenesis inhibitory effect of sunitinib malate. Fundus photography and angiographic, electrophysiologic, and histopathologic evaluations with light and electron microscopy were performed in two groups of five rabbits each that received different intravitreal concentrations of the drug. Each rabbit received 0.1 ml of sunitinib malate in the right eye (one group with 12.5 mg/ml, the other group with 25 mg/ml); all animals received 0.1 ml of physiologic saline solution in the left eye. After sacrifice, the eyes were enucleated and fixed with modified Karnovsky solution.Results: No toxicity related to sunitinib malate was observed using an in vitro model with the 12.5 and 25 mg/ml solutions in HUVEC and ARPE cell cultures. No toxicity was observed in the in vivo model with 12.5 mg/ml, but light microscopy showed that the 25 mg/ml solution damaged the photoreceptors layer. No functional changes in the electroretinogram were observed in any group.Conclusions: Sunitinib malate 12.5 mg/ml caused no toxicity in in vivo and in vitro models, but the 25 mg/ml concentration caused retinal changes suggesting toxicity in the in vivo model. Further research with the drug is needed in models of ocular neovascularization.
URI: http://repositorio.unifesp.br/handle/11600/35085
ISSN: 0271-3683
Other Identifiers: http://dx.doi.org/10.3109/02713683.2011.635916
Appears in Collections:Artigo

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.